AIRLINK 195.75 Increased By ▲ 0.92 (0.47%)
BOP 9.83 Increased By ▲ 0.02 (0.2%)
CNERGY 7.40 Increased By ▲ 0.04 (0.54%)
FCCL 40.45 Increased By ▲ 1.87 (4.85%)
FFL 16.36 Decreased By ▼ -0.09 (-0.55%)
FLYNG 28.79 Increased By ▲ 1.25 (4.54%)
HUBC 132.45 Increased By ▲ 0.70 (0.53%)
HUMNL 13.95 Increased By ▲ 0.09 (0.65%)
KEL 4.59 Decreased By ▼ -0.07 (-1.5%)
KOSM 6.70 Increased By ▲ 0.04 (0.6%)
MLCF 46.31 Increased By ▲ 0.92 (2.03%)
OGDC 214.50 Increased By ▲ 0.51 (0.24%)
PACE 6.81 Decreased By ▼ -0.05 (-0.73%)
PAEL 40.57 Increased By ▲ 0.51 (1.27%)
PIAHCLA 16.94 Increased By ▲ 0.15 (0.89%)
PIBTL 8.45 Increased By ▲ 0.13 (1.56%)
POWER 9.75 Increased By ▲ 0.32 (3.39%)
PPL 183.32 Increased By ▲ 1.13 (0.62%)
PRL 42.14 Increased By ▲ 0.31 (0.74%)
PTC 24.87 Increased By ▲ 0.31 (1.26%)
SEARL 104.20 Increased By ▲ 1.67 (1.63%)
SILK 1.00 No Change ▼ 0.00 (0%)
SSGC 39.80 Increased By ▲ 0.36 (0.91%)
SYM 17.48 Increased By ▲ 0.15 (0.87%)
TELE 8.78 Increased By ▲ 0.02 (0.23%)
TPLP 12.67 Decreased By ▼ -0.08 (-0.63%)
TRG 66.21 Increased By ▲ 0.81 (1.24%)
WAVESAPP 11.15 Increased By ▲ 0.04 (0.36%)
WTL 1.70 No Change ▼ 0.00 (0%)
YOUW 3.96 Increased By ▲ 0.02 (0.51%)
BR100 12,023 Increased By 48.7 (0.41%)
BR30 36,466 Increased By 319.8 (0.88%)
KSE100 113,675 Increased By 231.9 (0.2%)
KSE30 35,710 Increased By 74.6 (0.21%)
World

Brazil regulator says Bharat Biotech vaccine does not meet factory standards

  • The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
Published March 30, 2021

SAO PAULO: Brazilian health regulator Anvisa said Bharat Biotech's Covaxin COVID-19 does not meet its manufacturing standards, according to a note in the Tuesday edition of the official gazette.

The Brazilian government signed a contract last month to buy 20 million doses of the Indian drugmaker's vaccine. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.

Comments

Comments are closed.